Find clinical trials for Heart Disease in Houston, TX
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Heart Disease trials near Houston, TX, USA:
other places in the body (metastatic). Telotristat ethyl and somatostatin analog therapy may help to control carcinoid syndrome and carcinoid heart...
Phase 3
Houston, Texas, United States
non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of advanced, refractory, left ventricular heart...
Houston, Texas, United States and 36 other locations
study device is a stent that is designed to maintain patency of the Ductus Arteriosus for children who need blood flow through that part of the heart...
Houston, Texas, United States and 7 other locations
imaging agent for quantification of the effect of neurodegenerative diseases on myocardial sympathetic innervation. Effectiveness of 18F-mFB...
Phase 2
Houston, Texas, United States
) application in patients with symptomatic heart disease due to failure of a surgical or transcatheter bioprosthetic aortic valve w...
Houston, Texas, United States and 84 other locations
The purpose of this study is to evaluate the device performance and monitor the safety and effectiveness of the Berlin Heart EXCOR Active Dr...
Houston, Texas, United States and 14 other locations
PumpKIN is a multicenter, prospective, single-arm feasibility study; Evaluating the investigational Jarvik 2015 VAD in pediatric patients with heart...
Early Phase 1
Houston, Texas, United States and 6 other locations
of the Cordella™ Pulmonary Artery Sensor System in NYHA Class II-III Heart Failure Patients (PROACTIVE-HF-2 Trial).The study contains of 5 a...
Houston, Texas, United States and 50 other locations
native aortic regurgitation who are judged by a multi-disciplinary heart team to be eligible for the device and to be at high risk for open ...
Houston, Texas, United States and 8 other locations
This study will evaluate the clinical efficacy and safety of udenafil, an orally administered, potent and selective inhibitor of PDE5, versus placebo...
Phase 3
Houston, Texas, United States and 39 other locations
Clinical trials
Research sites
Resources
Legal